Hitting the Right Target? Lab Studies Suggest Epigenetic Drug May Fight Childhood Brain Cancer

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to NIH Director's Blog for National Institutes of Health (NIH).   Hitting the Right Target? Lab Studies Suggest Epigenetic Drug May Fight Childhood Brain Cancer 05/19/2015 09:00 AM EDT Every year in the United States, several hundred children and their families receive a devastating diagnosis: diffuse intrinsic pontine glioma (DIPG). Sadly, this inoperable tumor of the brain stem, little known by the public, is almost always fatal, and efforts to develop life-saving treatments have been hampered by a lack of molecular data to identify […] Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612

Tweet

Postingan terkait:

— Tuesday, May 19, 2015 — Add Comment